ANNOVIS BIO INC. COMMON STOCK

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs

15 окт 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases

03 окт 2024 05:30:00 Источник Nasdaq GlobeNewswire

Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations

02 окт 2024 05:30:00 Источник Nasdaq GlobeNewswire

Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

30 сен 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference

05 сен 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Reports Second Quarter Financial Results and Provides Business Update

15 авг 2024 04:00:00 Источник Nasdaq GlobeNewswire

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

06 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap

24 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap

16 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

09 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Announces New Data from Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Cognition after Treatment with Buntanetap

02 июл 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

27 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

26 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data

25 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio Highlights New Alzheimer’s Data at the Alzheimer’s Association International Conference® 2024

18 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients

11 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire

Annovis Announces New Publication in a Peer-Reviewed Journal

21 май 2024 04:30:00 Источник Nasdaq GlobeNewswire

Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results

13 май 2024 04:30:00 Источник Nasdaq GlobeNewswire

Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease

09 май 2024 04:30:00 Источник Nasdaq GlobeNewswire

Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders

06 май 2024 04:30:00 Источник Nasdaq GlobeNewswire